Lilly's orforglipron consistent with injectable GLP-1 medicines

According to an official statement from Eli Lilly and Company, "Orforglipron is the first oral small-molecule...

Glycemic control in people with type 2 diabetes can be predicted

Machine learning techniques can predict with certainty the likelihood that patients with type 2 diabetes would have...

Glenmark launches drug for treating type 2 diabetes

This fixed-dose combination has been launched under the brand name Zita-PioMet, and contains Teneligliptin (20 mg),...

Glenmark becomes the first company to launch Remogliflozin +...

Mumbai (Maharashtra) [India], December 29 . (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a...

People with type 2 diabetes need not avoid eating potatoes...

Washington [US], October 26 (ANI): New study findings show that people with type 2 diabetes can better maintain...

DayTwo to Scale Microbiome research platform with USD 31...

San Francisco (California) [USA] July 03 (ANI/NewsVoir): DayTwo, the microbiome human discovery platform that offers...